| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbffa3b81b3b862dc7220b5648f5f745 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-912
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc25de8def2817d86dd452bf056f1ad7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945a733806f8805bedd59c00fd8eec05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78891684335e8b9ea45cc80bbf8e1f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405bb8b4b6f79fa3d48ab410b18bcf59 |
| publicationDate |
2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150142932-A |
| titleOfInvention |
Brain somatic mutations associated to epilepsy and uses thereof |
| abstract |
The present invention relates to a cerebral somatic genetic variation causing cerebral apoplexy and its use in relation to intractable cerebral apoplexy due to cerebral cortical development abnormality. More specifically, the present invention relates to a mTOR protein (mTOR) in which the mutation of the base sequence occurs, or the mTOR protein in which the mutation of the amino acid sequence occurs due to the mutation of the base sequence. In addition, the present invention relates to a diagnostic technique of intractable cerebral apoplexy due to cerebral cortical development malformation using the gene or protein. In addition, the present invention relates to a technique for inducing intractable cerebral infarction by cerebral cortical development malformation using a gene or protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019004703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190002146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190002147-A |
| priorityDate |
2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |